This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Feb 1;180(2):309-310.

doi: 10.1001/jamainternmed.2019.5443.

Getting Serious About Opioid Regulation

William K Hubbard¹

Affiliations

PMID: 31886829
DOI: 10.1001/jamainternmed.2019.5443

Comment

Getting Serious About Opioid Regulation

William K Hubbard. JAMA Intern Med. 2020.

. 2020 Feb 1;180(2):309-310.

doi: 10.1001/jamainternmed.2019.5443.

Author

William K Hubbard¹

Affiliation

¹ Chapel Hill, North Carolina.

PMID: 31886829
DOI: 10.1001/jamainternmed.2019.5443

No abstract available

PubMed Disclaimer

Comment on

Evaluation of the Extended-Release/Long-Acting Opioid Prescribing Risk Evaluation and Mitigation Strategy Program by the US Food and Drug Administration: A Review.
Heyward J, Olson L, Sharfstein JM, Stuart EA, Lurie P, Alexander GC. Heyward J, et al. JAMA Intern Med. 2020 Feb 1;180(2):301-309. doi: 10.1001/jamainternmed.2019.5459. JAMA Intern Med. 2020. PMID: 31886822 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information